High-Dose Chemo Helps Beat Rare Br... ( Many patients achieved long-term remi...)

High-Dose Chemo Helps Beat Rare Brain Cancer

Date:1/30/2008

Many patients achieved long-term remission without radiation, study finds

WEDNESDAY, Jan. 30 (HealthDay News) -- Most people suffering from a rare brain cancer appear to benefit from high doses of the chemotherapy drug methotrexate, a small study finds.

Primary central nervous system lymphoma (PCNSL) is a type of non-Hodgkin lymphoma that affects the brain. Although it is typically very difficult to treat, it can be cured or sent into long remissions. Current treatment is often a combination of radiation and chemotherapy. Newer approaches involve giving chemotherapy first, and waiting on radiation until the results of chemotherapy are seen.

However, "A subset of these patients with a rare form of non-Hodgkin lymphoma appeared to be cured by chemotherapy alone," explained lead researcher Dr. Tracy Batchelor, from the Massachusetts General Hospital Cancer Center in Boston.

Batchelor, who is executive director of the Stephen E. & Catherine Pappas Center for Neuro-Oncology at the hospital, noted there are about 1,500 new cases of PCNSL diagnosed in the United States each year.

In the study, Batchelor's group treated 25 adults with newly diagnosed PCNSL with a high dose of methotrexate every two weeks for four months, or until there were no signs of the brain tumor. The patients were followed for a minimum of 6.5 years.

The report appears in the Jan. 29 issue of Neurology.

Batchelor's team found that 52 percent of the patients had a complete remission of their cancer and 40 percent had not had a relapse after seven years. Average survival of all patients who received methotrexate was 4.5 years, compared with one year among patients who had radiation therapy.

It's clear that methotrexate is the best drug to treat this tumor, Batchelor said. "The drug attacks cells that are dividing. Other drugs don't have as high a response rate," he explained.

Batchelor note
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. High-Dose Chemo Provides Little Benefit to Breast Cancer Patients
2. High-dose chemo and stem cell transplant shows little or no survival benefit for breast cancer
3. Explaining chemotherapy-associated nausea
4. Combined radiation seed, chemotherapy wafer implants show promise in treating cancerous brain tumors
5. ChemoCentryx Appoints Edward E. Penhoet, Ph.D., to Board of Directors
6. Class of Chemotherapy Drugs Helps Certain Breast Cancer Patients
7. Chemotherapy and tamoxifen reduce risk of second breast cancer
8. Modeling Simulation Predicts Potential Negative Impact on U.S. Blood Supply if ESA Use Limited for Chemotherapy-Induced Anemia
9. Gentler chemotherapy before stem cell transplant causes long-term remission of follicular lymphoma
10. Extracellular protein sensitizes ovarian cancer cells to chemotherapy
11. Chemoprevention, naturally: Findings on plant-derived cancer medicines

Post Your Comments:

High-Dose Chemo Helps Beat Rare Br...( Many patients achieved long-term remi...),Health